Latest Insider Transactions at Lantheus Holdings, Inc. (LNTH)
This section provides a real-time view of insider transactions for Lantheus Holdings, Inc. (LNTH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Lantheus Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Lantheus Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 05
2024
|
Sam R Leno |
BUY
Exercise of conversion of derivative security
|
Direct |
2,045
+3.3%
|
$32,720
$16.3 P/Share
|
Mar 05
2024
|
Jean Claude Provost Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Indirect |
546
-1.39%
|
$35,490
$65.36 P/Share
|
Mar 04
2024
|
Sam R Leno |
SELL
Open market or private sale
|
Direct |
22,389
-14.66%
|
$1,455,285
$65.2 P/Share
|
Mar 04
2024
|
Sam R Leno |
BUY
Exercise of conversion of derivative security
|
Direct |
22,389
+7.11%
|
$537,336
$24.77 P/Share
|
Mar 04
2024
|
Robert J. Marshall Jr. CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
29,762
+14.94%
|
-
|
Mar 04
2024
|
Paul Blanchfield President |
BUY
Grant, award, or other acquisition
|
Direct |
16,910
+10.63%
|
-
|
Mar 04
2024
|
Mary Anne Heino Director |
SELL
Open market or private sale
|
Direct |
93,863
-9.69%
|
$6,101,095
$65.54 P/Share
|
Mar 04
2024
|
Mary Anne Heino Director |
BUY
Grant, award, or other acquisition
|
Direct |
81,169
+19.02%
|
-
|
Mar 04
2024
|
Etienne Montagut Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,645
+15.26%
|
-
|
Mar 04
2024
|
Daniel Niedzwiecki |
BUY
Grant, award, or other acquisition
|
Direct |
6,466
+5.9%
|
-
|
Mar 04
2024
|
Andrea Sabens Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,817
+7.68%
|
-
|
Mar 01
2024
|
Robert J. Marshall Jr. CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
36,547
+20.73%
|
-
|
Mar 01
2024
|
Paul Blanchfield President |
BUY
Grant, award, or other acquisition
|
Direct |
36,547
+22.6%
|
-
|
Mar 01
2024
|
Jean Claude Provost Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
18,564
+32.03%
|
-
|
Mar 01
2024
|
Etienne Montagut Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,326
+24.11%
|
-
|
Mar 01
2024
|
Daniel Niedzwiecki |
BUY
Grant, award, or other acquisition
|
Direct |
30,456
+23.94%
|
-
|
Mar 01
2024
|
Brian A Markison CEO |
BUY
Grant, award, or other acquisition
|
Direct |
131,496
+46.25%
|
-
|
Mar 01
2024
|
Andrea Sabens Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,685
+8.15%
|
-
|
Feb 13
2024
|
Andrea Sabens Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
341
-0.58%
|
$18,755
$55.31 P/Share
|
Jan 16
2024
|
Andrea Sabens Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
341
-0.58%
|
$19,096
$56.01 P/Share
|
Dec 15
2023
|
Robert J. Marshall Jr. CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
10,000
-8.84%
|
$780,000
$78.24 P/Share
|
Dec 13
2023
|
Andrea Sabens Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
341
-0.57%
|
$25,575
$75.62 P/Share
|
Dec 13
2023
|
Mary Anne Heino Director |
SELL
Bona fide gift
|
Direct |
53,350
-16.79%
|
-
|
Nov 16
2023
|
Paul Blanchfield President |
SELL
Open market or private sale
|
Direct |
1,500
-1.66%
|
$100,500
$67.96 P/Share
|
Nov 13
2023
|
Andrea Sabens Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
341
-0.57%
|
$21,483
$63.57 P/Share
|
Nov 13
2023
|
Mary Anne Heino Director |
SELL
Open market or private sale
|
Direct |
11,780
-1.8%
|
$742,140
$63.72 P/Share
|
Sep 15
2023
|
Daniel Niedzwiecki |
SELL
Open market or private sale
|
Direct |
2,846
-4.12%
|
$187,836
$66.43 P/Share
|
Sep 15
2023
|
Daniel Niedzwiecki |
BUY
Exercise of conversion of derivative security
|
Direct |
2,846
+3.95%
|
$48,382
$17.79 P/Share
|
Aug 29
2023
|
Robert J. Marshall Jr. CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
4,872
+4.13%
|
-
|
Aug 21
2023
|
Paul Blanchfield President |
SELL
Open market or private sale
|
Direct |
408
-0.45%
|
$26,928
$66.1 P/Share
|
Aug 18
2023
|
Paul Blanchfield President |
SELL
Open market or private sale
|
Direct |
1,500
-1.63%
|
$97,500
$65.19 P/Share
|
Aug 15
2023
|
Robert J. Marshall Jr. CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
10,000
-8.45%
|
$680,000
$68.52 P/Share
|
Aug 11
2023
|
Mary Anne Heino Director |
SELL
Open market or private sale
|
Direct |
10,950
-1.62%
|
$744,600
$68.53 P/Share
|
Aug 11
2023
|
Daniel Niedzwiecki |
SELL
Open market or private sale
|
Direct |
4,297
-6.09%
|
$287,899
$67.93 P/Share
|
Jul 19
2023
|
Andrea Sabens Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,752
-2.85%
|
$157,680
$90.87 P/Share
|
Jul 18
2023
|
Paul Blanchfield President |
SELL
Payment of exercise price or tax liability
|
Direct |
518
-0.56%
|
$45,066
$87.4 P/Share
|
Jun 02
2023
|
Minnie Baylor Henry |
SELL
Open market or private sale
|
Indirect |
6
-27.27%
|
$516
$86.22 P/Share
|
May 18
2023
|
Daniel Niedzwiecki |
SELL
Payment of exercise price or tax liability
|
Direct |
1,466
-2.03%
|
$142,202
$97.97 P/Share
|
May 18
2023
|
Paul Blanchfield President |
SELL
Bona fide gift
|
Direct |
250
-0.27%
|
-
|
May 18
2023
|
Paul Blanchfield President |
SELL
Open market or private sale
|
Direct |
1,500
-1.59%
|
$145,500
$97.93 P/Share
|
May 15
2023
|
Robert J. Marshall Jr. CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
10,000
-7.79%
|
$990,000
$99.36 P/Share
|
May 15
2023
|
Andrea Sabens Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
385
-0.62%
|
$38,115
$99.36 P/Share
|
May 11
2023
|
Brian A Markison CEO |
BUY
Grant, award, or other acquisition
|
Direct |
2,012
+8.62%
|
-
|
May 11
2023
|
Julie Mc Hugh |
BUY
Grant, award, or other acquisition
|
Direct |
2,012
+6.6%
|
-
|
May 11
2023
|
Heinz Christoph Maeusli |
BUY
Grant, award, or other acquisition
|
Direct |
2,012
+6.51%
|
-
|
May 11
2023
|
Minnie Baylor Henry |
BUY
Grant, award, or other acquisition
|
Direct |
2,012
+29.94%
|
-
|
May 11
2023
|
Sam R Leno |
BUY
Grant, award, or other acquisition
|
Direct |
2,012
+3.36%
|
-
|
May 11
2023
|
Daniel Niedzwiecki |
SELL
Open market or private sale
|
Direct |
6,113
-7.82%
|
$599,074
$98.82 P/Share
|
May 11
2023
|
Gerard Ber |
BUY
Grant, award, or other acquisition
|
Direct |
2,012
+5.48%
|
-
|
May 11
2023
|
James H Thrall |
BUY
Grant, award, or other acquisition
|
Direct |
2,012
+5.82%
|
-
|